Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-245259

10% owner sold 18,572 shares at $40.05 ($743,753)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures V, L.P. 10% owner 2026-05-26 Sale 10b5-1 −18,572 $40.05 $743,753 6,280,525 D: show line 1 in the form
Open-market sales · 18,572 sh · avg $40.05 · $743,753
Loading xslF345X06/ownership.xml…